JF
Jens Fricke
About Jens Fricke
Data last updated:
Jens Fricke is a Director at Polypeptide Laboratories Private Limited (since 2023). The company operates in Pharma. Polypeptide Laboratories Private Limited reported revenue of ₹94.10 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Polypeptide Laboratories Private Limited U51397MH2001PTC130734 | Director | 01 Mar 2023 | 2001 | ₹94.10 Cr (FY 2025) | Active |
Board colleagues of Jens Fricke
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Dattatraya Alate | 00491315 | Polypeptide Laboratories Private Limited | Director |
| Juan Jose Gonzalez Casanova | 10214229 | Polypeptide Laboratories Private Limited | Director |
| Navleen Kaur Surinder Anand | Polypeptide Laboratories Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jens Fricke
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jens Fricke
Jens Fricke currently holds 1 directorship: Polypeptide Laboratories Private Limited (Director, since 01 Mar 2023, revenue ₹94.10 Cr (FY 2025)).
Jens Fricke was first appointed on 01 Mar 2023 as Director at Polypeptide Laboratories Private Limited.
The current boards of Jens Fricke's companies include Ashok Dattatraya Alate (Polypeptide Laboratories Private Limited), Juan Jose Gonzalez Casanova (Polypeptide Laboratories Private Limited), Navleen Kaur Surinder Anand (Polypeptide Laboratories Private Limited).